NCT00096655View on ClinicalTrials.gov

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

August 31, 2007

Conditions
Ulcerative Colitis
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY